Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vitrolife AB, headquartered in Sweden, is a leading provider of products and systems for in-vitro fertilization (IVF) and cell therapy. The company develops, manufactures, and distributes innovative solutions to improve fertility and support stem cell therapies. Vitrolife AB supports clinics worldwide with high-quality IVF kits, culture media, and cell culture products, driving advancements in reproductive medicine and regenerative therapies.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vitrolife AB is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vitrolife AB last reported quarterly earnings on 7/16/2026 (Q2 2026). Earnings per share (EPS) came in at 0.96 SEK.
Vitrolife AB has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.